Periadventitial adipose tissue (tunica adiposa): Enemy or friend around? [1]

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 12, 2007, Pages 1766-

  Chaldakov, George N ^a   Tonchev, Anton B ^a   Stankulov, Ivan S ^a   Ghenev, Peter I ^a   Fiore, Marco ^b   Aloe, Luigi ^b   Ranĉiĉ, Gorana ^c   Panayotov, Plamen ^d   Rostov, Dimitar D ^d  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b CNR   (Italy)

^c Medical Faculty   (Serbia)

^d UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE;

ADIPOSE TISSUE; ADVENTITIA; ATHEROSCLEROSIS; CELL GROWTH; CELL MIGRATION; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; EPICARDIUM; HUMAN; HYPERTENSION; INTIMA; LETTER; METABOLIC SYNDROME X; MOUSE STRAIN; NONHUMAN; OBESITY; SMOOTH MUSCLE FIBER; TUNICA MEDIA;

ADIPOSE TISSUE; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CONNECTIVE TISSUE; HUMANS;

EID: 37349094979     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Vela D, Buja M, Madjid M, et al. The role of periadventitial fat in atherosclerosis: an adipose subset with potential diagnostic and therapeutic implications. Arch Pathol Lab Med. 2007;131:481-487.
2. Tellides G. Periadventitial fat: regional source of inflammation in atherosclerosis. Arch Pathol Lab Med. 2007;131:346-347.
3. Chaldakov GN, Stankulov IS, Aloe L. Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. Atherosclerosis. 2001;154:237-238.
4. Töre F, Tonchev AB, Fiore M, et al. From adipose tissue protein secretion to adipopharmacology of disease. Immunol Endocr Metab Agents Med Chem. 2007;7:149-155.
5. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol. 2007;151:323-331.
6. Yudkin JS, Eringa E, Stehouwer CDA. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365:1817-1820.